Archive for February 7th, 2012

CUR offering. ANAC trial on hold. OREX cardio trial update

Feb 07, 2012 No Comments by

Neuralstem, Inc. (NYSE Amex: CUR) announced today a registered direct placement of 5.2m shares of common stock at a price of $1.00 per share for aggregate gross proceeds of $5.2m. Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that its partner GlaxoSmithKline (GSK) has voluntarily paused enrollment in its current clinical trials of GSK2251052 (GSK ‘052) due to a recently identified microbiological finding […]

Daily News Read more